Kids with high-risk neuroblastoma face a less than 5% chance of survival. Until now, there were no proven treatment options. Thanks to the 2023 Forbes/SHOOK Top Advisor Summit kids with this cancer now have a new hope of being cured with new immunotherapies in clinical trial.

Visit https://childrenscancer.org/shook/ to learn more.